middle.news
Neurotech Secures $4.73m Boost for Paediatric Neurological Drug Trials
9:53am on Wednesday 12th of November, 2025 AEDT
•
Healthcare
Read Story
Neurotech Secures $4.73m Boost for Paediatric Neurological Drug Trials
9:53am on Wednesday 12th of November, 2025 AEDT
Key Points
Received $4.73 million R&D tax incentive refund for FY2025
Funds to advance clinical trials targeting paediatric neurological disorders
Focus on Autism Spectrum Disorder, PANDAS/PANS, Rett Syndrome, and cerebral palsy
Clinical-stage biopharmaceutical company with promising trial results
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Neurotech International (ASX:NTI)
OPEN ARTICLE